Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01749215 · ClinicalTrials.gov registry record · Phase 4
A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 151
- Enrollment target
NCT01749215 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 151 participants.
The verdict
NCT01749215, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 151 participants
- Enrollment target
Study Summary
The goal of this project is to improve the treatment of veterans with co-occurring alcohol dependence and posttraumatic stress disorder (PTSD). The PI and co-investigators will conduct a controlled clinical trial of topiramate for the treatment of these co-occurring disorders.
Interventions
- DRUG placebo
- BEHAVIORAL Medical Management
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2013-02 |
| Est. Completion | 2019-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01749215
The ClinicalTrials.gov registry entry for NCT01749215 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT01749215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01749215 about?
NCT01749215 is a clinical study titled "A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD". The goal of this project is to improve the treatment of veterans with co-occurring alcohol dependence and posttraumatic stress disorder (PTSD). The PI and co-investigators will conduct a controlled clinical trial of topiramate for the treatment of these co-occurring disorders.
What is the current status of trial NCT01749215?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 151 participants. The study started on 2013-02. Estimated completion is 2019-07.
What interventions are being tested in trial NCT01749215?
The interventions under investigation include: placebo (DRUG), Medical Management (BEHAVIORAL), Topiramate (DRUG).
Who is sponsoring clinical trial NCT01749215?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.